Corebridge Financial Inc. lowered its position in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 5.5% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 276,685 shares of the company's stock after selling 16,027 shares during the quarter. Corebridge Financial Inc. owned 0.16% of Option Care Health worth $6,419,000 as of its most recent SEC filing.
A number of other hedge funds have also modified their holdings of OPCH. UMB Bank n.a. boosted its holdings in Option Care Health by 41.7% in the 4th quarter. UMB Bank n.a. now owns 1,176 shares of the company's stock worth $27,000 after buying an additional 346 shares during the period. Signaturefd LLC grew its stake in Option Care Health by 487.9% during the fourth quarter. Signaturefd LLC now owns 1,211 shares of the company's stock valued at $28,000 after acquiring an additional 1,005 shares in the last quarter. Quarry LP increased its holdings in Option Care Health by 327.7% in the 3rd quarter. Quarry LP now owns 3,430 shares of the company's stock valued at $107,000 after acquiring an additional 2,628 shares during the last quarter. Blue Trust Inc. grew its position in shares of Option Care Health by 16.9% during the fourth quarter. Blue Trust Inc. now owns 4,703 shares of the company's stock valued at $109,000 after purchasing an additional 681 shares in the last quarter. Finally, Venturi Wealth Management LLC increased its holdings in shares of Option Care Health by 2,621.3% in the fourth quarter. Venturi Wealth Management LLC now owns 4,735 shares of the company's stock worth $110,000 after purchasing an additional 4,561 shares during the last quarter. 98.05% of the stock is currently owned by institutional investors.
Insider Activity at Option Care Health
In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of the firm's stock in a transaction that occurred on Friday, February 28th. The stock was sold at an average price of $33.26, for a total value of $1,030,926.96. Following the sale, the insider now directly owns 44,974 shares of the company's stock, valued at approximately $1,495,835.24. This trade represents a 40.80 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.64% of the stock is currently owned by insiders.
Option Care Health Stock Performance
OPCH stock traded up $0.22 during midday trading on Monday, reaching $34.95. The stock had a trading volume of 1,527,150 shares, compared to its average volume of 1,713,078. The company has a debt-to-equity ratio of 0.77, a quick ratio of 1.32 and a current ratio of 1.73. The firm has a fifty day simple moving average of $32.47 and a two-hundred day simple moving average of $28.38. The stock has a market cap of $5.74 billion, a PE ratio of 29.37, a P/E/G ratio of 2.30 and a beta of 1.33. Option Care Health, Inc. has a 52-week low of $21.39 and a 52-week high of $35.53.
Analyst Upgrades and Downgrades
OPCH has been the topic of a number of research reports. JMP Securities restated a "market outperform" rating and issued a $30.00 target price (down from $31.00) on shares of Option Care Health in a report on Friday, January 10th. UBS Group assumed coverage on shares of Option Care Health in a research note on Thursday, December 5th. They issued a "neutral" rating and a $26.00 target price on the stock. Jefferies Financial Group raised shares of Option Care Health from a "hold" rating to a "buy" rating and raised their price objective for the stock from $26.00 to $35.00 in a research note on Thursday, January 23rd. Barrington Research boosted their target price on shares of Option Care Health from $33.00 to $38.00 and gave the company an "outperform" rating in a research note on Thursday, February 27th. Finally, JPMorgan Chase & Co. lifted their price objective on Option Care Health from $40.00 to $41.00 and gave the company an "overweight" rating in a report on Thursday, March 6th. Two research analysts have rated the stock with a hold rating and six have issued a buy rating to the company. According to MarketBeat, Option Care Health presently has an average rating of "Moderate Buy" and a consensus price target of $33.00.
Check Out Our Latest Research Report on Option Care Health
About Option Care Health
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Read More
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
